Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

@article{Choopanya2013AntiretroviralPF,
  title={Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial},
  author={K. Choopanya and Michael Martin and P. Suntharasamai and Udomsak Sangkum and P. Mock and M. Leethochawalit and Sithisat Chiamwongpaet and Praphan Kitisin and Pitinan Natrujirote and Somyot Kittimunkong and R. Chuachoowong and R. Gvetadze and J. Mcnicholl and L. Paxton and M. Curlin and C. Hendrix and S. Vanichseni},
  journal={The Lancet},
  year={2013},
  volume={381},
  pages={2083-2090}
}
BACKGROUND Antiretroviral pre-exposure prophylaxis reduces sexual transmission of HIV. We assessed whether daily oral use of tenofovir disoproxil fumarate (tenofovir), an antiretroviral, can reduce HIV transmission in injecting drug users. METHODS In this randomised, double-blind, placebo-controlled trial, we enrolled volunteers from 17 drug-treatment clinics in Bangkok, Thailand. Participants were eligible if they were aged 20-60 years, were HIV-negative, and reported injecting drugs during… Expand
HIV pre-exposure prophylaxis in injecting drug users
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 42 REFERENCES
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Preexposure prophylaxis for HIV infection among African women.
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
...
1
2
3
4
5
...